Ma. Moses et al., TEMPORAL STUDY OF THE ACTIVITY OF MATRIX METALLOPROTEINASES AND THEIRENDOGENOUS INHIBITORS DURING WOUND-HEALING, Journal of cellular biochemistry, 60(3), 1996, pp. 379-386
The restoration of functional connective tissue is a major goal of the
wound healing process. This regenerative event requires the depositio
n and accumulation of collagenous and noncollagenous matrix molecules
as well as the remodelling of extracellular matrix (ECM) by matrix met
alloproteinases (MMPs). In this study, we have utilized substrate gel
electrophoresis, radiometric enzyme assays, and Western blot analyses
to determine the temporal pattern of appearance and activity of active
and latent MMPs and their inhibitors during the entire healing proces
s in a partial thickness wound model. Through the use of substrate gel
electrophoresis, we studied the appearance of proteolytic bands whose
molecular weight was consistent with their being members of the MMP f
amily of enzymes. Proteolytic bands whose molecular weight is consiste
nt with both the active and latent forms of MMP-2 (72 kDa, Type IV gel
atinase) were detected in wound fluid of days 1-7 after wounding. The
number of active MMP-2 species detectable in wound fluid was greatest
during days 4-6 after wounding. The most prominent proteolytic band de
tected each day migrated with a molecular weight consistent with it be
ing the latent form of MMP-9 (92 kDa, Type V pro-collagenase). In cont
rast to MMP-2, the active form of this enzyme was never detected. The
presence of MMP-1 (interstitial collagenase) was detected by immunoblo
t in the wound fluid from days 1-6 post-injury. Using a radiometric en
zyme assay for collagenase inhibitory activity we have also determined
the time course of activity of endogenous matrix metalloproteinase in
hibitors. We have correlated these data to the known eel Iu lar events
occurring in the wound during this time period as well. This study es
tablishes a prototypical pattern of MMP appearance in normal wound hea
ling. It may also provide potential intervention sites for the therape
utic use of inhibitors of aberrant MMP activities which characterize c
hronic wounds. (C) 1996 Wiley-Liss, Inc.